Navigation Links
Rest for the Weary: Pain Relief for Diabetics with Painful Neuropathy
Date:11/5/2013

WALTHAM, Mass., Nov. 5, 2013 /PRNewswire/ -- Way back in the 17th century, John Donne, English attorney, cleric and preeminent representative of the metaphysical poets, wrote: "Sleep is pain's easiest salve, as doth fulfill all offices of death, except to kill." Today, those words could especially resonate with the estimated three to five million U.S. men and women with Type 2 diabetes who suffer from Painful Diabetic Neuropathy (PDN), as half of them report trouble falling or remaining asleep.

PDN is a manifestation of diabetic neuropathy, a common complication of diabetes that results from nerve damage due to high blood glucose (sugar) levels. PDN can bring about symptoms such as burning, stabbing and hypersensitivity in the feet, and can severely limit patients' daily functions.

Unfortunately, even when treated with pain medications, only one in four patients with PDN reports 50 percent relief. Furthermore, PDN is non-discriminatory, in that it lasts through the night. Given the difficulty these patients can already experience in their daily routines, what can be done to help relieve their pain while they sleep? And perhaps even provide daytime pain relief as well?

Fortunately, one innovative company understands the importance of Donne's sentiments, especially for PDN patients. That company is NeuroMetrix, Inc., a medical device company headquartered in Waltham, Massachusetts, focused on the neurological complications of diabetes. Its team, led by Chief Executive Officer Shai N. Gozani, M.D., Ph.D., has created the SENSUS™ Pain Management System, to help those who suffer from PDN find rapid, non-narcotic pain relief both while awake and during sleep—or "pain's easiest salve," as Donne would say.

As Dr. Gozani explains, "The sleep cycle is essential for the repair, rebuilding and recharging of the human body and its natural systems. For the millions who are afflicted with PDN, pain symptoms can actually worsen at nighttime, according to studies published in medical journals."

SENSUS is a lightweight, wearable transcutaneous electrical nerve stimulation (TENS) device that provides fast-acting pain relief as a complement to pain medications. It's the first such device to receive 510(k) clearance from the U.S. Food and Drug Administration (FDA) for use during sleep.

For more on how to manage PDN with SENSUS, ask your doctor, or visit www.neurometrix.com, which paid for the writing and dissemination of this release.

Contact: Laura Radocaj, Dian Griesel Int'l., 212.825.3210


'/>"/>
SOURCE NeuroMetrix, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. BD Launches BD Helping Build Healthy Communities with Direct Relief and the National Association of Community Health Centers
2. Treating Poison Ivy Is A Snap! New Cortizone 10 Poison Ivy Relief Pads Launch Just In Time For Summer
3. BioElectronics Enters Malaysias Pain Relief Market
4. BioElectronics Unique Pain Relief Product Featured on Leading Healthcare Show in Spain
5. Zimmer Launches Single Injection Pain Relief Solution at the 2013 AAOS Annual Meeting
6. Timely Analysis of Pain Relief Costs and Outcomes Finds Disproportionate Risks for Seniors
7. Breakthrough Procedure Provides Relief for Acid Reflux
8. India Wound Care Management Market Outlook to 2018 - Advanced Wound Management, Wound Closure Devices, Pressure Relief Devices, Ostomy Drainage Bags and Others
9. BRICS NPWT Market and Pressure Relief Devices Industry Analysis in New Research Reports at ReportsnReports.com
10. Pressure Relief Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018
11. North America Wound Care Management Market Outlook to 2018 - Advanced Wound Management, Wound Closure Devices, Pressure Relief Devices, Ostomy Drainage Bags and Other
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... Feb 24, 2017 Research and Markets has announced ... - 2016" report to their offering. ... The latest research Dry eye Drugs Price Analysis and ... Dry eye market. The research answers the following questions: ... and their clinical attributes? How are they positioned in the Global Dry ...
(Date:2/24/2017)... 2017 Juan Monteverde , founder and ... a boutique securities firm headquartered at the Empire State ... announces that a class action lawsuit has been filed in ...  against Inotek Pharmaceuticals Corporation (NASDAQ:  ITEK)("Inotek" or the "Company") ... 23, 2015 and December 30, 2016, inclusive (the "Class ...
(Date:2/24/2017)... ITL Limited, ( ASX : ITD ), une ... d,annoncer les excellents résultats semestriels clos le 31 décembre ... présentation complète « Résultats et mise à jour sur la ... Faits marquants ... $ ; en hausse de 104 %) Bénéfice ...
Breaking Medicine Technology:
(Date:2/24/2017)... ... 24, 2017 , ... Dr. Ronald E. Hawkins, vice president ... of Peter A. Bell, DO, MBA, HPF, FACOEP-dist., FACEP, as the new dean ... Dr. Bell comes to Liberty from the Ohio University Heritage College of Osteopathic ...
(Date:2/24/2017)... ... 2017 , ... Healthcare Associates of McKinney announced today that they ... 8080 State Highway 121, Suite 210, McKinney, Texas 75070. It is in the ... As the practice has grown, the need for more space has been paramount. ...
(Date:2/24/2017)... ... 24, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House of ... generation. Yisrayl makes an astounding statement when he says that the entire Bible ... Bible details the current times so plainly that anyone should be able to see ...
(Date:2/24/2017)... ... February 24, 2017 , ... Rosica Communications, a national ... leadership , media relations, social media, content marketing and SEO, is now offering ... Act-On, an intuitive marketing automation platform. , Rosica will now offer the platform ...
(Date:2/23/2017)... ... February 23, 2017 , ... On February 22, 2017 ... letter to withdraw previous guidance issued by the Obama Administration requiring schools ... in May 2016 by the Obama Administration came in response to a growing ...
Breaking Medicine News(10 mins):